LON:CLC Calculus VCT (CLC) Share Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free CLC Stock Alerts GBX 60 0.00 (0.00%) (As of 04/24/2024 01:41 AM ET) Add Compare Share Share Today's Range 56.25▼ 6050-Day Range 50▼ 6052-Week Range 45▼ 70Volume312,631 shsAverage Volume21,357 shsMarket Capitalization£38.06 millionP/E Ratio6,000.00Dividend Yield5.00%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendStock AnalysisChartCompetitorsDividend Get Calculus VCT alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About Calculus VCTCalculus VCT plc, formerly known as Investec Structured Products Calculus VCT PLC, is a venture capital trust specializing in venture capital investments.Read More CLC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLC Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive CLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Calculus VCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:CLC CUSIPN/A CIKN/A Webwww.calculuscapital.com Phone44 20 7493 4940FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.01 Trailing P/E Ratio6,000.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£1.93 million Net Margins-9.46% Pretax MarginN/A Return on Equity-0.22% Return on Assets-0.14% Debt Debt-to-Equity RatioN/A Current Ratio9.42 Quick Ratio19.51 Sales & Book Value Annual Sales£1.53 million Price / Sales24.88 Cash FlowGBX 10.08 per share Price / Cash Flow5.95 Book ValueGBX 62 per share Price / Book0.97Miscellaneous Outstanding Shares63,440,000Free FloatN/AMarket Cap£38.06 million OptionableNot Optionable Beta0.39 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key CompetitorsBlackRock Income and GrowthLON:BRIGCEIBA InvestmentsLON:CBAOctopus Future Generations VCTLON:OFGMomentum Multi-Asset Value TrustLON:MAVTNB Global Monthly Income FundLON:NBMIView All Competitors CLC Stock Analysis - Frequently Asked Questions How have CLC shares performed in 2024? Calculus VCT's stock was trading at GBX 60 at the beginning of 2024. Since then, CLC stock has increased by 0.0% and is now trading at GBX 60. View the best growth stocks for 2024 here. How often does Calculus VCT pay dividends? What is the dividend yield for Calculus VCT? Calculus VCT declared a dividend on Friday, June 30th. Investors of record on Thursday, July 27th will be given a dividend of GBX 2.95 per share on Friday, August 25th. This represents a dividend yield of 4.72%. The ex-dividend date of this dividend is Thursday, July 27th. The official announcement can be seen at this link. Read our dividend analysis for CLC. Is Calculus VCT a good dividend stock? Calculus VCT (LON:CLC) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 4.92%. CLC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 30,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for CLC. How do I buy shares of Calculus VCT? Shares of CLC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CLC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calculus VCT plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
